⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

September 1, 2020International Journal of Hematologic OncologyOpen Access

Incidence of Venous Thrombosis After Peg-Asparaginase in Adolescent and Young Adults with Acute Lymphoblastic Leukemia

Brynne Underwood Qiuhong Zhao Alison R. Walker Alice S. Mims Sumithira Vasu Meixiao Long Tamanna Haque Bradley W. Blaser Nicole R. Grieselhuber Sarah Wall Gregory K. Behbehani James S. Blachly Karilyn Larkin John C. Byrd Ramiro Garzon Tzu‐Fei Wang Bhavana Bhatnagar

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

These data indicate a high rate of VTE in the AYA ALL population following treatment with peg-asparaginase.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Underwood et al. (2020) studied this question.

synapsesocial.com/papers/69dcbc3189c4deb67d3596ed https://doi.org/10.2217/ijh-2020-0009

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Real-world treatment patterns, healthcare resource utilization and total cost of care in mantle cell lymphoma from US commercial claimsInternational Journal of Hematologic Oncology · 2023
2Improved Survival of Adolescents and Young Adults Patients with T-Cell Acute Lymphoblastic LeukemiaInternational Journal of Hematologic Oncology · 2023
3Beyond Monoclonal Gammopathy of Undetermined Significance, Clinical Spectrum of Immunoglobulin M Gammopathy: A Case Series with Focus on the Diagnostic and Management ChallengesInternational Journal of Hematologic Oncology · 2023
4Therapy-Related Core Binding Factor Acute Myeloid LeukemiaInternational Journal of Hematologic Oncology · 2023
5Pediatric-Type Follicular Lymphoma: A Short ReviewInternational Journal of Hematologic Oncology · 2022
6Turkey Real-Life Data: Demographic Features, Treatment Results and Effects of Comorbidities in Chronic Myeloid LeukemiaInternational Journal of Hematologic Oncology · 2022
7Adhesion Molecules in Multiple Myeloma Oncogenesis and Targeted TherapyInternational Journal of Hematologic Oncology · 2022
8The Effect of Comorbidities on the Choice of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid LeukemiaInternational Journal of Hematologic Oncology · 2022
9The Use of Hypomethylating Agents in Hematologic Malignancies: Treatment Preferences and ResultsInternational Journal of Hematologic Oncology · 2021
10A Phase I Trial of Talazoparib in Patients with Advanced Hematologic MalignanciesInternational Journal of Hematologic Oncology · 2021

More from International Journal of Hematologic Oncology

More from The Ohio State University